Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$34.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 2 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 9 most recent Form 4 transactions.
| May 4 | SPTX | Seaport Therapeutics, Inc. | PBUY | 1.1M | $18.00 | $19.8M | +21.2% | Open the original filing on SEC.gov |
| May 4 | SPTX | Seaport Therapeutics, Inc. | CCONV | 2.7M | — | — | +106.7% | Open the original filing on SEC.gov |
| May 4 | SPTX | Seaport Therapeutics, Inc. | CCONV | 2.5M | — | — | — | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | DTOISS | 8.3M | — | — | -100.0% | Open the original filing on SEC.gov |
| Nov 13, 2025 | MTSR | Metsera, Inc. | DTOISS | 18.5M | — | — | -100.0% | Open the original filing on SEC.gov |
| Oct 27, 2025 | NMRA | Neumora Therapeutics, Inc. | PBUY | 1.9M | $2.61 | $5M | +46.4% | Open the original filing on SEC.gov |
| Aug 1, 2025 | PRME | Prime Medicine, Inc. | PBUY | 3M | $3.30 | $10M | +94.7% | Open the original filing on SEC.gov |